Researchers analyzed hundreds of studies to identify a diet that optimizes human health and longevity.
- They found that diets low in animal protein and high in complex carbohydrates that include periods of fasting are most beneficial for long-term health and life span.
- However, the researchers note that their findings simply provide a foundation for understanding and that, in practice, diets should be tailored to individual needs and circumstances.
In around 440 B.C., the Greek physician Hippocrates said “Let food be thy medicine and let thy medicine be food.”
Although treating food as medicine is a highly debated concept, many recent studies have demonstrated the wisdom in this statement and how monitoring
However, what precisely makes up the optimal diet remains controversial. Growing evidence suggests optimal diets may depend on an interplay of health factors, including age, sex, and genetics.
Recently, researchers reviewed hundreds of nutrition studies from cellular to epidemiological perspectives to identify a “common denominator nutrition pattern” for healthy longevity.
They found that diets including mid-to-high levels of unrefined carbohydrates, a low but sufficient plant-based protein intake, and regular fish consumption were linked to an extended lifespan and healthspan.
Dr. Valter Longo, professor of gerontology and biological sciences at the University of Southern California, and one of the authors of the study, told Medical News Today:
“First, diet here is intended as a nutritional lifestyle and not as a ‘weight-loss strategy’ although maintaining a healthy weight is key. All aspects of the diet are linked to long-term health and longevity.”
“I am delighted to see this review,” Dr. Pankaj Kapah, professor of gerontology at the University of Southern California, who was not involved in the study, told MNT.
“Generally when one thinks of a longevity diet, the first thing that comes to mind is what we can add to our diet to live longer. This article is important to raise the awareness that the most striking benefits from studies across species have come from limiting the diet or fasting.”
— Dr. Pankaj Kapah
The review was published in the journal
For the study, the researchers analyzed hundreds of studies examining nutrition and delayed aging in short-lived species, nutrient response pathways, caloric restriction, fasting, and diets with various macronutrient and composition levels, such as the keto diet.
The studies analyzed nutrition and diet from multiple angles, from cellular and animal studies to clinical and epidemiological research investigating the lifestyles of centenarians.
In the end, the researchers found that the ‘longevity diet’ includes:
- A legume and whole grain-rich pescatarian or vegetarian diet
- 30% of calories from vegetable fats such as nuts and olive oil
- A low but sufficient protein diet until age 65 and then moderate protein intake
- Low sugar and refined carbs
- No red or processed meat
- Limited white meat
- 12 hours of eating and 12 of fasting per day
- Around three cycles of a five-day fasting-mimicking diet per year
The researchers further noted that, rather than targeting a certain number of calories, diets should aim to keep BMI under 25 and maintain ideal sex and age-specific body fat and lean body mass levels.
Moreover, they wrote that diets should be adapted to individual needs—especially for those over 65—to avoid malnourishment. Those over 65, for example, may become frail from a low protein diet.
For those without insulin resistance or obesity, high consumption of complex carbohydrates could reduce frailty in this age group and others, the researchers wrote, as it provides energy without increasing insulin and activating glucose signaling pathways.
The researchers also found that periodic fasting between the ages of 18 and 70 could reverse insulin resistance generated by a high calorie diet and regulate blood pressure, total cholesterol, and inflammation.
A recent study supports these findings. It found that changing from the typical Western diet to one rich in legumes, whole grains, and nuts with reduced red and processed meats is linked to an 8-year-longer life expectancy if started at age
The researchers noted that diets involving calorie and protein restriction were consistently beneficial, whether in short-lived species or om epidemiological studies and large clinical trials.
They further noted that low but sufficient protein, or a recommended protein intake with high levels of legume consumption, could increase the health span by reducing the intake of amino acids including methionine. Methionine has been linked to increased activity in various pro-aging cellular pathways.
When asked how the longevity diet may benefit health from a clinical perspective, Kristin Kirkpatrick, a registered dietitian nutritionist at the Cleveland Clinic and advisor to Dr. Longo’s firm, Prolon, told MNT:
“The diet is primarily plant-based which, based on other similar studies, may contribute to lower risk of chronic conditions such as type 2 diabetes and cardiovascular disease.”
“Plant-based diets have also been associated with lower inflammation levels in multiple studies. As inflammation is the base of many diseases, this may contribute to the longevity factors as well,” she explained.
The researchers conclude that their findings provide solid foundations for future research into nutritional recommendations for healthy longevity.
When asked about the study’s limitations, Dr. Longo, Dr. Kapahi, and Kirkpatrick stressed that there is no ‘one-size-fits-all’ approach. The optimal diet, they say, may differ due to factors including sex, age, genetic makeup, and any sensitivities and intolerances, such as an intolerance to gluten.
Dr. Longo thus recommends people visit a dietician before undertaking a new diet.
Kirkpatrick added that many of her patients visit her when making dietary changes to ensure they are sustainable in the long term.
FROM OUR EXPERT NUTRITIONISTS
Could rapamycin be our next weapon in the fight for longevity?
- Rapamycin, also known as sirolimus, is an immunosuppressant drug that was approved by the Food and Drug Administration (FDA) in 1999.
- Researchers have known about the drug’s ability to increase life expectancy in mice and model organisms for nearly a decade.
- A recent study has investigated whether dosing for a brief period in early adulthood could have a lifelong anti-aging impact, with fewer side effects.
Life expectancy has increased steadily over the past
While lifespan has increased, the so-called
Part of the reason for this is that the processes that underpin the health decline that occurs with aging are poorly understood and difficult to control.
As we age we are more likely to experience cardiovascular disease, type 2 diabetes, cataracts, hearing loss, and dementia, as well as a decrease in immunity and muscle mass, and there are a number of theories as to why.
There are divergent theories about the causes of aging, and different researchers are focusing on different targets to prevent or slow aging in order to improve health in old age, and potentially increase longevity.
While lifestyle changes are recommended to improve health in older people, they are not sufficient to prevent age-related decline. Also, lifestyle interventions can be challenging to maintain. Thus, researchers are looking at the potential of pharmaceutical interventions.
One of these potential pharmaceutical interventions is the use of rapamycin. Also known as sirolimus, it was initially approved by the FDA in 1999 as an immunosuppressant for transplant patients. Researchers also found that rapamycin had anticancer properties.
Eventually, yet another property of the drug was discovered: longevity and a reduction in age-related disease.
Evidence that rapamycin could potentially inhibit the aging process was first proposed in the journal Cell Cycle in 2006 by Dr. Mikhail Blagosklonny, a researcher on aging at the Roswell Park Comprehensive Cancer Center in Buffalo, NY.
His hypothesis was confirmed by a study carried out by researchers at Novartis and Stanford University, CA, and published in Science Translational Medicine in 2014.
Speaking to Medical News Today, he said the next question was whether or not giving rapamycin at a particular point in early adulthood could have long lasting effects.
This is exactly what a recent paper by researchers from the Max Planck Institute for Biology of Ageing, in Cologne, Germany has looked at, in fruit flies and mice. The paper appears in Nature Aging
“At the doses used clinically, rapamycin can have undesirable side effects, but for the use of the drug in the prevention of age-related decline, these need to be absent or minimal. Therefore, we wanted to find out when and how long we need to give rapamycin in order to achieve the same effects as lifelong treatment,” explains Dr. Paula Juricic, the leading investigator on this study.
Dr. Juricic works in the department of Prof. Dame Linda Partridge, director at the Max Planck Institute for Biology of Ageing.
The study authors found that when young adult drosophila, a type of fruit fly used as a genetic model organism, received rapamycin for 2 weeks, the drug appeared to protect them against age-related changes found in the intestine and extended their lives.
They showed that this was due to an upregulation of the mechanisms in the cell responsible for recycling parts of the cell that have become defective called autophagy, in the intestine. This upregulation was persistent and due to the cells in the intestine retaining a memory of the drug, the authors said.
The drug was also given to mice for 3 months starting at 3 months of age, equivalent to early adulthood, and improvements were seen in the integrity of the gut barrier in middle age. They also found that the effects of the drug could still be detected 6 months after they stopped the treatment.
Dr. Dao-Fu Dai, assistant professor of pathology at the University of Iowa Health Care, who has carried out research on the effect of rapamycin in mice, said the paper was “exciting,” but noted that the next step would be to see how reproducible the results in drosophila would be in a mammalian system.
He told Medical News Today in an interview:
“I think the paper is very exciting. The things that need to be done in the future will involve [the] mammalian system, right, because drosophila is much easier to do; mammals take much longer time. Doing it in mammals is rather limited because they only focus on [the] intestinal system and then they look at the gut barrier system in mammals because the whole drosophila story is also based on protecting the gut barrier system [in this study].”
Dr. Alessandro Bitto, acting instructor in the Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, who has also studied the effect of rapamycin in mice, said that identifying when to give rapamycin for a lifelong effect in mammals was a difficult issue.
Lifelong intervention with rapamycin has an effect due to a higher drug dose, he explained: “The question is, is there period of treatment in a mouse or a mammal in general where if we give rapamycin in that window we have the same effect, as lifelong intervention?”
This would reduce the amount of the drug that would need to be given overall, and hopefully reduce risks and problematic side effects.
Source - Medical News Today
No comments:
Post a Comment